- Home
- CORT vs LNTH Comparison
CORT vs LNTH Comparison
Compare CORT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- LNTH
- Stock Information
- Founded
- CORT 1998
- LNTH 1956
- Country
- CORT United States
- LNTH United States
- Employees
- CORT N/A
- LNTH N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CORT Health Care
- LNTH Health Care
- Exchange
- CORT Nasdaq
- LNTH Nasdaq
- Market Cap
- CORT 7.1B
- LNTH 7.5B
- IPO Year
- CORT N/A
- LNTH 2015
- Fundamental
- Price
- CORT $70.59
- LNTH $78.95
- Analyst Decision
- CORT Strong Buy
- LNTH Strong Buy
- Analyst Count
- CORT 4
- LNTH 5
- Target Price
- CORT $142.00
- LNTH $133.80
- AVG Volume (30 Days)
- CORT 1.4M
- LNTH 1.3M
- Earning Date
- CORT 05-05-2025
- LNTH 05-07-2025
- Dividend Yield
- CORT N/A
- LNTH N/A
- EPS Growth
- CORT 8.36
- LNTH N/A
- EPS
- CORT 1.14
- LNTH 3.53
- Revenue
- CORT $685,446,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- CORT $35.85
- LNTH $5.81
- Revenue Next Year
- CORT $35.22
- LNTH $12.26
- P/E Ratio
- CORT $61.82
- LNTH $22.69
- Revenue Growth
- CORT 30.93
- LNTH 12.53
- 52 Week Low
- CORT $25.35
- LNTH $74.34
- 52 Week High
- CORT $117.33
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CORT 50.86
- LNTH 27.93
- Support Level
- CORT $69.33
- LNTH $78.61
- Resistance Level
- CORT $73.36
- LNTH $83.60
- Average True Range (ATR)
- CORT 3.66
- LNTH 3.87
- MACD
- CORT -0.20
- LNTH -3.13
- Stochastic Oscillator
- CORT 39.15
- LNTH 1.12
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.